Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten(R)
23 Januar 2007 - 1:00PM
Business Wire
Akorn, Inc. (AMEX: AKN) today announced the positive results of a
Phase III pivotal trial for Akten�. The clinical trial was a
randomized, placebo controlled, multi-centered, 4-arm trial in 209
subjects. The primary efficacy end point for achieving ocular
anesthesia (p
Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AMEX:AKN)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AMEX:AKN)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (Amerikanische Börse): 0 Nachrichtenartikel
Weitere Akorn, Inc. News-Artikel